Article: Sanofi pasteur Influenza Vaccine Production Tops 170 Million Doses in 2006.

- Record Production Capabilities Strengthen sanofi pasteur's Global Leadership in the Fight Against Seasonal Influenza and Place the Company at the Forefront of Pandemic Readiness -

LYON, France, and SWIFTWATER, Pa., Dec. 20 /PRNewswire-FirstCall/ -- Sanofi pasteur, the vaccines business of the sanofi-aventis Group (NYSE: SNY; EURONEXT: SAN), announced that it completed production of more than 170 million doses of influenza vaccine in 2006. Sanofi pasteur confirmed its leadership as one of the world's largest manufacturers of seasonal influenza vaccine, supplying a very significant portion of the estimated global production of about 350 million doses(1).

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!